Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Donev investments holding_Sopharma_EN_2024.03.08_Buyxlsx.pdf.p7sNotification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2024
Date of issue: 2024-03-11
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
Annexes
File Description
Donev investments holding_Sopharma_EN_2024.03.08_Buyxlsx.pdf.p7s
Donev investments holding_Sopharma_EN_2024.03.08_Buyxlsx.pdf.p7s		 Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-03-11 Ognian Donev Executive director
20240311_135658_1546975859_Donev_investments_holding_Sopharma_EN_2024.03.08_Buyxlsx.pdf.p7s

Pobierz